Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.
about
Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Lactoferrin-modified rotigotin ...... , and neuroprotective effects.
@en
Lactoferrin-modified rotigotin ...... , and neuroprotective effects.
@nl
type
label
Lactoferrin-modified rotigotin ...... , and neuroprotective effects.
@en
Lactoferrin-modified rotigotin ...... , and neuroprotective effects.
@nl
prefLabel
Lactoferrin-modified rotigotin ...... , and neuroprotective effects.
@en
Lactoferrin-modified rotigotin ...... , and neuroprotective effects.
@nl
P2860
P50
P356
P1476
Lactoferrin-modified rotigotin ...... , and neuroprotective effects.
@en
P2860
P304
P356
10.2147/IJN.S151475
P4011
72195e5d5cafa51a9fa2840e83d0dba56abfaac1
P407
P577
2018-01-09T00:00:00Z